Characterization of PXR mediated P-glycoprotein regulation in intestinal LS174T cells

Pharmacological Research

Volumn 62, Issue 5, 2010, Pages 426-431

  Kota, Bhavani Prasad ^a   Tran, Van H ^a   Allen, John ^a   Bebawy, Mary ^a   Roufogalis, Basil D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Function; Induction; Intestinal P glycoprotein; Localization; LS174T; Rifampicin

Indexed keywords

GLYCOPROTEIN P; KETOCONAZOLE; PREGNANE X RECEPTOR; RHODAMINE 123; RIFAMPICIN;

ARTICLE; CELL COMPARTMENTALIZATION; CELL LINE; CELL MEMBRANE; CELL STRAIN LS174T; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EXPOSURE; DRUG SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

CELL LINE, TUMOR; CELL MEMBRANE; DRUG INTERACTIONS; HUMANS; INTESTINES; P-GLYCOPROTEIN; RECEPTORS, STEROID; RHODAMINE 123; RIFAMPIN; RNA, MESSENGER; VERAPAMIL;

EID: 77956944501     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.07.001     Document Type: Article

References (37)

1. Higgins C.F. ABC transporters: from microorganisms to man. Annu Rev Cell Biol 1992, 8:67-113.
2. Ambudkar S.V., Kim I.W., Sauna Z.E. The power of the pump: mechanisms of action of P-glycoprotein (ABCB1). Eur J Pharm Sci 2006, 27:392-400.
3. Lin J.H., Yamazaki M. Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet 2003, 42:59-98.
4. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., Willingham M.C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987, 84:7735-7738.
5. Cordon-Cardo C., O'Brien J.P., Boccia J., Casals D., Bertino J.R., Melamed M.R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990, 38:1277-1287.
6. Hsing S., Gatmaitan Z., Arias I.M. The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa. Gastroenterology 1992, 102:879-885.
7. Ito K., Kusuhara H., Sugiyama Y. Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption-theoretical approach. Pharm Res 1999, 16:225-231.
8. Van Asperen J., Van Tellingen O., Beijnen J.H. The pharmacological role of P-glycoprotein in the intestinal epithelium. Pharmacol Res 1998, 37:429-435.
9. Geick A., Eichelbaum M., Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 2001, 276:14581-14587.
10. Greiner B., Eichelbaum M., Fritz P., Kreichgauer H.P., von Richter O., Zundler J., et al. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 1999, 104:147-153.
11. Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharm Res 1997, 14:763-766.
12. Artursson P., Palm K., Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 2001, 46:27-43.
13. Pfrunder A., Gutmann H., Beglinger C., Drewe J. Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J Pharm Pharmacol 2003, 55:59-66.
14. Goto M., Masuda S., Saito H., Inui K. Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2. Biochem Pharmacol 2003, 66:163-170.
15. Anderle P., Niederer E., Rubas W., Hilgendorf C., Spahn-Langguth H., Wunderli-Allenspach H., et al. P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. J Pharm Sci 1998, 87:757-762.
16. Haslam I.S., Jones K., Coleman T., Simmons N.L. Induction of P-glycoprotein expression and function in human intestinal epithelial cells (T84). Biochem Pharmacol 2008, 76:850-861.
17. Haslam I.S., Jones K., Coleman T., Simmons N.L. Rifampin and digoxin induction of MDR1 expression and function in human intestinal (T84) epithelial cells. Br J Pharmacol 2008, 154:246-255.
18. Collett A., Tanianis-Hughes J., Warhurst G. Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions?. Biochem Pharmacol 2004, 68:783-790.
19. Maier A., Zimmermann C., Beglinger C., Drewe J., Gutmann H. Effects of budesonide on P-glycoprotein expression in intestinal cell lines. Br J Pharmacol 2007, 150:361-368.
20. Gupta A., Mugundu G.M., Desai P.B., Thummel K.E., Unadkat J.D. Intestinal human colon adenocarcinoma cell line LS180 is an excellent model to study pregnane X receptor, but not constitutive androstane receptor, mediated CYP3A4 and multidrug resistance transporter 1 induction: studies with anti-human immunodeficiency virus protease inhibitors. Drug Metab Dispos 2008, 36:1172-1180.
21. Rutzky L.P., Kaye C.I., Siciliano M.J., Chao M., Kahan B.D. Longitudinal karyotype and genetic signature analysis of cultured human colon adenocarcinoma cell lines LS180 and LS174T. Cancer Res 1980, 40:1443-1448.
22. Tom B.H., Rutzky L.P., Jakstys M.M., Oyasu R., Kaye C.I., Kahan B.D. Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro 1976, 12:180-191.
23. Huang L., Wring S.A., Woolley J.L., Brouwer K.R., Serabjit-Singh C., Polli J.W. Induction of P-glycoprotein and cytochrome P450 3A by HIV protease inhibitors. Drug Metab Dispos 2001, 29:754-760.
24. Oscarson M., Burk O., Winter S., Schwab M., Wolbold R., Dippon J., et al. Effects of rifampicin on global gene expression in human small intestine. Pharmacogenet Genomics 2007, 17:907-918.
25. Hustert E., Zibat A., Presecan-Siedel E., Eiselt R., Mueller R., Fuss C., et al. Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4. Drug Metab Dispos 2001, 29:1454-1459.
26. Cerveny L., Pavek P., Malakova J., Staud F., Fendrich Z. Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents. Epilepsia 2006, 47:461-468.
27. Burk O., Arnold K.A., Nussler A.K., Schaeffeler E., Efimova E., Avery B.A., et al. Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol 2005, 67:1954-1965.
28. Svecova L., Vrzal R., Burysek L., Anzenbacherova E., Cerveny L., Grim J., et al. Azole antimycotics differentially affect rifampicin-induced pregnane X receptor-mediated CYP3A4 gene expression. Drug Metab Dispos 2008, 36:339-348.
29. Takeshita A., Taguchi M., Koibuchi N., Ozawa Y. Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics. J Biol Chem 2002, 277:32453-32458.
30. Huang H., Wang H., Sinz M., Zoeckler M., Staudinger J., Redinbo M.R., et al. Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole. Oncogene 2007, 26:258-268.
31. Lin J.H. Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Adv Drug Deliv Rev 2003, 55:53-81.
32. Fromm M.F., Kim R.B., Stein C.M., Wilkinson G.R., Roden D.M. Inhibition of P-glycoprotein-mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidine. Circulation 1999, 99:552-557.
33. Takano M., Hasegawa R., Fukuda T., Yumoto R., Nagai J., Murakami T. Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells. Eur J Pharmacol 1998, 358:289-294.
34. Engdal S., Nilsen O.G. Inhibition of P-glycoprotein in Caco-2 cells: effects of herbal remedies frequently used by cancer patients. Xenobiotica 2008, 38:559-573.
35. Cummins C.L., Jacobsen W., Benet L.Z. Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 2002, 300:1036-1045.
36. Jiang H., Chen K., He J., Pan F., Li J., Chen J., et al. Association of pregnane X receptor with multidrug resistance-related protein 3 and its role in human colon cancer chemoresistance. J Gastrointest Surg 2009, 13:1831-1838.
37. Fu D., Bebawy M., Kable E.P., Roufogalis B.D. Dynamic and intracellular trafficking of P-glycoprotein-EGFP fusion protein: implications in multidrug resistance in cancer. Int J Cancer 2004, 109:174-181.